L'hormone de croissance recombinante : Intérêt et risques potentiels de son utilisation pour la production laitière bovine

Productions Animales

Volumn 11, Issue 1, 1998, Pages 15-32

  Chilliard, Y ^d   Colleau, J J ^a   Disenhaus, C ^b   Lerondelle, C ^d   Mouchet, C ^c   Paris, A ^a  

^a CEMAGREF   (France)

^b ENSA Sciences Animales   (France)

^c ENSA Syst Prod Developpement Rural   (France)

^d INRA Lab des Xénobiotiques ^*

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0039393949     PISSN: 09900632     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Bareille N., Faverdin P., Hay M., 1997. Modification of feed intake response to a beta (2)-agonist by bovine somatotropin in lactating or dry dairy cows. J. Dairy Sci., 80, 52-66.
2. Bauman D.E., Vernon R.G., 1993. Effects of exogenous bovine somatotropin on lactation. Annu. Rev. Nutr., 13, 437-461.
3. Bruneau P., DeKerchove G., 1988. Somatotropine, reproduction et génétique chez la vache laitière. Elevage et insémination, 228, 3-14.
4. Bruneau P., Bertrand G., Chilliard Y., De Kerchove G., 1991. Somatotropine bovine (Sometribove) et production laitière. Efficacité et innocuité chez 448 paires de vaches dans les conditions de 24 exploitations françaises. Rec. Méd. Vét., 167, 859-872.
5. Burton J.L., Mc Bride B.W., Block E., Glimm D.R., Kenelly J.J., 1994. A review of bovine growth hormone. Can. J. Anim. Sci., 74, 167-201.
6. Burvenich C., Vandeputte-van Messon G., Rœts E., Fabry J., Massart-Leen A.M., 1989b. Effect of bovine somatotropin on milk yield and milk composition in periparturient cows experimentally infected with Escherichia coli. In : K. Sejrsen, M. Vestergaard and A. Neimann-Sorensen (eds), Use of Somatotropin in Livestock Production, 277-280. Elsevier Applied Science, London.
7. Chilliard Y., 1988b. Review. Long term effects of recombinant bovine somatotropin (rBST) on dairy cow performances. Ann. Zootech., 37, 159-180.
8. Chilliard Y., 1990. Somatotropine et lactation. Données récentes présentées au séminaire Monsanto (Telfs, Autriche, 9-11 mars 1990). Rec. Med. Vet., 166, 513-516.
9. Chilliard Y., 1993. Les adaptations métaboliques et le partage des nutriments chez l'animal en lactation. In : J. Martinet et L.M. Houdebine (eds), Biologie de la lactation, 431-475. INSERM-INRA, Paris.
10. Chilliard Y., Vérité R., Pflimlin A., 1989. Effets de la Somatotropine bovine sur les performances des vaches laitières dans les conditions françaises d'élevage. INRA Prod. Anim., 2, 301-312.
11. Chilliard Y., Cissé M., Lefaivre R., Rémond B., 1991. Body composition of dairy cows according to lactation stage, somatotropin and concentrate supplementation. J. Dairy Sci., 74, 3103-3116.
12. Colleau J.J., 1990b. Effet de la somatotropine bovine (BST) sur l'efficacité des programmes de sélection laitière. INRA Prod. Anim., 3, 93-102.
13. Colleau J.J., 1996. Evaluation génétique des animaux d'élevage. INRA Prod. Anim., no hors série 50 ans de recherches en productions animales, 27-40.
14. Cordonnier P., Bonnafous P., 1989. Essai d'appréciation de l'impact économique des utilisations de la somatotropine bovine dans les systèmes laitiers français. INRA Economie et Sociologie Rurale, Notes et Documents, 138 p.
15. De La Sota R.L., Lucy M.C., Staples C.R., Thatcher W.W., 1993. Effect of recombinant bovine somatotropin (Sometribove) on ovarian function in lactating and non lactating dairy cows. J. Dairy Sci., 76, 1002-1013.
16. Disenhaus C., 1996. La somatotropine bovine recombinée : réponses des ruminants en lactation. Thèse Institut National Agronomique Paris-Grignon (171 p).
17. Disenhaus C., Jammes H., Belair L., Kann G., Djiane J., 1992. Récepteurs hépatiques à la somatotropine et récepteurs mammaires à la prolactine et à l'IGF1 après injections de somatotropine bovine recombinée chez la chèvre en lactation. Ann. Zootech., 41, 111-112.
18. Downer J.V., Patterson D.L., Rock D.W., Chalupa W.V., Cleale R.M., Firkins J.L., Lynch G.L., Clark J.H., Brodie B.O., Jenny B.F., De Gregorio R., 1993. Dose titration of sustained-release recombinant bovine somatotropin in lactating dairy cows. J. Dairy Sci., 76, 1125-1136.
19. Driancourt M.A., Disenhaus C., 1997. Lack of effect of somatotropin administration on ovarian function of lactating goats. Anim. Reprod. Sci., 46, 123-132.
20. Falaki M., Prandi A., Corradini C., Sneyers M., Gengler N., Massart S., Fazzini U., Burny A., Portetelle D., Renaville R., 1997. Relationships of growth hormone gene and milk protein polymorphisms to milk production traits in Simmental cattle. J. Dairy Res., 64, 47-56.
21. Ferlay A., Chilliard Y., Sala A.M., Durier C., Bocquier F., 1996. Somatotropin treatment does not affect non esterified fatty acid response to adrenergic injections in underfed or overfed non lactating cows. J. Nutr., 126, 945-954.
22. Fu Y.K., Arkins S., Li Y.M., Dantzer R., Kelley K.W., 1994. Reduction in superoxide anion secretion and bactericidal activity of neutrophils from aged rats : reversal by the combination of gamma interferon and growth hormone. Infect. Immun., 62, 1-8.
23. Gallo G.F., Block E., 1990. Effect of recombinant bovine somatotropin on nutritional status and liver function of lactating dairy cows. J. Dairy Sci., 73, 3276-3286.
24. Hadsell D.L., Greenberg N.M., Fligger J.M., Baumrucker C.R., Rosen J.M., 1996. Targeted expression of des (1-3) human insulin-like growth factor-I (IGF I) in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinology, 137, 321-330.
25. Hartnell G.F., Franson S.E., Bauman D.E., Head H.H., Huber J.T., Lamb R.C., Madsen K.S., Cole W.J., Hintz R.L., 1991. Evaluation of Sometribove in a prolonged-release system in lactating dairy cows. Production responses. J. Dairy Sci., 74, 2645-2663.
26. Jammes H., Disenhaus C., Ouriet V., Kayser C., Postel-Vinay M.C., Djiane J., 1996. Growth hormon-binding protein in the goat : characterization, evolution under exogenous growth hormone treatment, and correlation with liver growth hormone receptor levels. Domest. Anim. Endocrinol., 13, 477-489.
27. Kelley K.W., 1989. Growth hormone, lymphocytes and macrophages. Biochem. Pharmacol., 38, 705-713.
28. Keys J.E., Van Zyl J.P., Farrell H.M. Jr., 1997. Effect of somatotropin and insulin-like growth factor-I on milk lipid and protein synthesis in vitro. J. Dairy Sci., 80, 37-45.
29. Knight C.H., Hillerton J.E., Kerr M.A., Teverson R.M., Turvey A., Wilde C.J., 1992. Separate and additive stimulation of bovine milk yield by the local and systemic galactopoietic stimuli of frequent milking and growth hormone. J. Dairy Res., 59, 243-252.
30. Lanna D.P.D., Houseknecht K.L., Harris D.M., Bauman D.E., 1995. Effect of somatotropin treatment on lipogenesis, lipolysis, and related cellular mechanisms in adipose tissue of lactating cows. J. Dairy Sci., 78, 1703-1712.
31. Lasmezas C., Deslys J.P., Dormont D., 1993. Recombinant human growth hormone and insulin-like growth factor 1 induce PrP gene expression in PC-12 cells. Biochem. Biophys. Res. Com., 196, 1163-1169.
32. Laurence J., Grimison B., Gonenne A., 1992. Effect of recombinant human growth hormone on acute and chronic human immunodeficiency virus infection in vitro. Blood, 79, 467-472.
33. Laurent F., Vignon B., Coomans D., Wilkinson J., Bonnel A., 1992. Influence of bovine somatotropin on the composition and manufacturing properties of milk. J. Dairy Sci., 75, 2226-2234.
34. Lynch J.M., Barbano D.M., Bauman D.E., Hartnell G.F., Nemeth M.A., 1992. Effect of a prolonged-release formulation of N-methionyl bovine somatotropin (Sometribove) on milk fat. J. Dairy Sci., 75, 1794-1809.
35. Maubois J.L., 1990. Incidence de l'utilisation du Sometribove, somatotropine bovine méthionylée recombinée, sur les propriétés technologiques du lait de vache et sur les qualités organoleptiques des produits résultants. Lait, 70, 369-382.
36. McGuffey R.K., Basson R.P., Snyder D.L., Block E., Harrison J.H., Rakes A.H., Emery R.S., Muller L.D., 1991. Effect of Somidobove sustained release administration on the lactation performance of dairy cows. J. Dairy Sci., 74, 1263-1276.
37. Melet J., Mouchet C., 1989. Impact microéconomique de la BST. Journée d'information sur la somatotropine bovine. Institut Technique de l'Elevage Bovin, Syndicat de l'Industrie du Médicament Vétérinaire. Paris, 18 Avril 1989, pp 43-56.
38. Mouchet C., 1988. Conséquences économiques de l'emploi de la BST dans la production laitière en France.Economie Rurale, no 192-193, 49-53.
39. Rémond B., Cissé M., Ollier A., Chilliard Y., 1991. Slow release somatotropin in dairy heifers and cows fed two levels of energy concentrate. I. Performance and body condition. J. Dairy Sci., 74, 1370-1381.
40. Rulquin H., Vérité R., 1993. The effects of bovine somatotropin injections on mammary blood flow in dry and lactating cows. Ann. Zootech., 42, 209.
41. Schams D., Graf F., Meyer J., Graule B., Mauthner M., Wollny C., 1991. Changes in hormones, metabolites, and milk after treatment with Sometribove (recombinant methionyl bST) in Deutches Fleckvieh and German Black and White cows. J. Anim. Sci., 69, 1583-1592.
42. Sharma B.K., Vendehaar M.J., Ames N.K., 1994. Expression of insulin-like growth factor I in cows at different stages of lactation and in late lactation cows treated with somatropin. J. Dairy Sci., 77, 2232-2241.
43. Stanisiewski E.P., McAllister J.F., Ash K.A., Taylor V.N., Kratzer D.D., Lauderdale J.W., 1994. Production performance of dairy cattle administered recombinant derived bovine somatotropin (USAN, Somavubove) daily : a dose range study. Domest. Anim. Endocrinol., 11, 239-260.
44. Thomas J.W., Erdman R.A., Galton D.M., Lamb R.C., Arambel M.J., Olson J.D., Madsen K.S., Samuels W.A., Peel C.J., Green G.A., 1991. Responses by lactating cows in commercial dairy herds to recombinant bovine somatotropin. J. Dairy Sci., 74, 945-964.
45. Vernon R.G., Faulkner A., Finley E., Watt P.W., Zammit V.A., 1995. Effects of prolonged treatment of lactating goats with bovine somatotropin on aspects of adipose tissue and liver metabolim. J. Dairy Res., 62, 237-248.
46. Willeberg P., 1993. Bovine somatotropin and clinical mastitis : epidemiological assessment of the welfare risk. Livest. Prod. Sci., 36, 55-66.
47. Witkamp R.F., Nijmeijer S.M., van Duin C.T.M., Bevers M.M., Wensing T.H., van Gogh H., van Miert A.S.J.P.A.M., 1989. Has somatotropin (bST) an effect upon drug disposition ? Comparative studies in goats and cattle with sulphamidine and antipyrine after parenteral administration of bST, zeranol and proligestone. J. Vet. Pharmacol. Therap., 12, 163-178.
48. Witkamp R.F., Nijmeijer S.M., van Duin C.T.M., Noordhœk J., van Miert A.S.J.P.A.M., 1993. The regulation of oxidative drug metabolism by growth hormone in the dwarf goat : differences from and similarities to the mechanisms in rats. J. Endocrinol., 136, 313-317.
49. Zhao F.Q., Moseley W.M., Tucker H.A., Kennelly J.J., 1996. Regulation of glucose transporter gene expression in mammary gland, muscle, and fat of lactating cows by administration of bovine growth hormone and bovine growth hormone-releasing factor. J. Anim. Sci., 74, 183-189.